Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1996-10-21
1998-08-25
Rotman, Alan L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514425, 548537, 548538, A61K 3140, C07D20708, C07D20709
Patent
active
057983771
ABSTRACT:
A compound which inhibits human thrombin and where has the structure ##STR1## such as ##STR2##
REFERENCES:
patent: 2277409 (1942-03-01), Murray
patent: 4346078 (1982-08-01), Bajusz et al.
patent: 4703036 (1987-10-01), Bajusz et al.
patent: 5252566 (1993-10-01), Shuman et al.
patent: 5332726 (1994-07-01), Klein et al.
patent: 5380713 (1995-01-01), Balasubramanian et al.
patent: 5416093 (1995-05-01), Shuman et al.
patent: 5510369 (1996-04-01), Lumma et al.
Hussain et al., Peptides, "Anticoagulant Activity of a Peptide Boronic Acid Thrombin Inhibitor by Various Routes of Administration in Rats", vol. 12, pp. 1153-1154 (1991).
Vencill et al., Chemical Abstracts, vol. 103, Abstract No. 18900 (1986).
Banner et al., Perspect. Med. Chem., "Chapter 3 --Serine Proteases: 3D Structures, Mechanisms of Action and Inhibitors", pp. 29-43 (1993).
Tapparelli et al., Tips, "Synthetic low-molecular weight thrombin inhibitors: molecular design and pharmacological profile", vol. 14, pp. 366-376, (1993).
Bajusz et al., J. Med. Chem., "Highly Active and Selective Anticoagulants: D-Phe-Pro-Arg-H, a Free Tripeptide Aldehyde Prone to Spontaneous Inactivation and Its Stable N-Methyl Derivative, D-Mephe-Pro-Arg-H", vol. 33, pp. 1729-1735 (1990).
Edwards et al., J. AM. Chem. Soc., "Design, Synthesis, and Kinetic Evaluation of a Unique Class of Elastase Inhibitors, the Peptidyl . . . ", vol. 114, pp. 1854-1863 (1992).
Berndt, M.C. and David R. Phillips, Department of Biochemistry, St. Jude Children's Research Hospital, "Chapter 3 --Platelet membrane proteins: composition and receptor function", pp. 43-75 (1981).
Martin et al., Biochemistry, "Platelet Stimulation by Thrombin and Other Proteases", vol. 14, No. 6, pp. 1308-1314 (1975).
Greco et al., Blood, PPACK-Thrombin Inhibits Thrombin-Induced Platelet Aggregation and Cytoplasmic Acidification but Does Not Inhibit Platelet Shape Change, vol. 75, No. 10, pp. 1983-1990 (1990).
Bode et al., The Embo Journal, "The refined 1.9 .ANG. crystal structure of human a-thrombin: interation with D-Phe-Pro-Arg chloromethylketone and significance of the . . . ", vol. 8, No. 11, pp. 3467-3475 (1989).
Workman et al., The Journal of Biological Chemistry "Structure-Function Relationships in the Interaction of a-Thrombin with Blood Platelets", vol. 252, No. 20, pp. 7118-7123 (1992).
Hui et al., Biochemical and Biophysical Research Communications, "Minimal Sequence Requirement of Thrombin Receptor Agonist Peptide", vol. 184, No. 2, pp. 790-796 (1992).
Scarborough et al., The Journal of Biological Chemistry, "Tethered Ligand Agonist Peptides Structural Requirements for Thrombin Receptor . . . ", vol. 267, No. 19, pp. 13146-13149 (1992).
Vassallo et al., The Journal of Biological Chemistry, "Structure-Function Relationships in the Activation of Platelet Thrombin Receptors by Receptor-derived Peptides", vol. 267, No. 9, pp. 6081-6085 (1992).
Iwanowicz et al., Organic & Medicinal Chemistry Letters, "a-Hydroxy-and a-Ketoester Functionalized Thrombin Inhibitors", vol. 2, No. 12, pp. 1607-1612 (1992).
Okumura et al., The Journal of Biological Chemistry, "Platelet Glycocalicin-Interaction with Thrombin and Role as Thrombin Receptor of the Platelet Surface", vol. 263, No. 10, pp. 3435-3443 (1978).
Tollefsen et al., The Journal of Biological Chemistry, "The Binding of Thrombin to the Surface of Human Platelets", vol. 249, No. 8, pp. 2646-2651 (1974).
Vu et al., Cell, "Molecular Cloning of a Functional Thrombin Receptor Reveals a Novel Proteolytic Mechanism of Receptor Activation", vol. 64, pp. 1057-1068 (1991).
Gronke et al., The Journal of Biological Chemistry, "Thrombin Interaction with Platelets-Influence of Platelet Protease Nexin", vol. 262, No. 7, pp. 3030-3036 (1987).
Phillips, D. R., Thrombos. Diathes. Haemorrh. (STUTTG.), "Thrombin Interaction with Human Platelets Potentiation of Thrombin-induced Aggregation and Release by Inactivated Thrombin", vol. 32, p. 207 (1974).
Balasubramanian et al., J. Med. Chem., "Active Site-Directed Synthetic Thrombin Inhibitors: Synthesis, in Vitro and in Vivo Activity Profile of BMY 44621 and . . . ", vol. 36, pp. 300-303 (1993).
Kettner et al., The Journal of Biological Chemistry, "The Selective Inhibition of Thrombin by Peptides of Boroarginine", vol. 265, No. 30, pp. 18289-18297 (1990).
Shuman et al., J. Med. Chem., "Highly Selective Tripeptide Thrombin Inhibitors", vol. 36, pp. 314-319 (1993).
Brady Stephen F.
Coburn Craig
Lumma William C.
Shafer Jules A.
Tucker Thomas J.
Merck & Co. , Inc.
Parr Richard S.
Rotman Alan L.
Winokur Melvin
LandOfFree
Thrombin inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Thrombin inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Thrombin inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-36666